PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A herbal formula (ELP) containing Fructus ligustri lucidi showed BMD protection in ovariectomized rats and demonstrated both osteoblastic and anti-osteoclastic action in vitro [PMID:24716161].
Specnuezhenide (SPN) ameliorates hepatic inflammation via the SIRT6-P2X7R axis [PMID:39097210] and mitigates tunicamycin-induced liver injury by modulating ER stress [PMID:40788369].
Specnuezhenide (SPN) attenuated bone destruction and joint inflammation in collagen-induced arthritis mice by regulating the KEAP1/NRF2 signaling pathway [PMID:41045622].
Specnuezhenide (SPN) increased peripheral blood cells and bone marrow nucleated cells in cyclophosphamide-induced mouse models [PMID:36852800].
Fruit extract (LLFE) inhibited proliferation and induced apoptosis in human Bel-7402 cells via upregulation of p21 [PMID:25017491].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36775079 (2023) — Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals. · Journal of ethnopharmacology
- 2.PMID: 37381954 (2023) — [Species identification of Ligustrum lucidum]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
- 3.PMID: 39097210 (2024) — Specnuezhenide ameliorates hepatic fibrosis via regulating SIRT6-Mediated inflammatory signaling cascades. · Journal of ethnopharmacology
- 4.PMID: 40803605 (2025) — Proteomic and transcriptomic analyses reveal new insights into allergens in Ligustrum lucidum pollen. · Journal of proteomics
- 5.PMID: 41045622